Immunomodulation of RA Patients’ PBMC with a Multiepitope Peptide Derived from Citrullinated Autoantigens

Table 1

Characterization of rheumatoid arthritis patients analyzed in the in vitro assays.

Patient number	Gender	Age	ACPA status	ACPA value
1	Female	35	Negative	12
2	Female	58	Moderate	49
3	Female	36	Moderate	48
4	Female	32	Weakly positive	26
5	Male	50	Highly positive	138
6	Female	38	Positive	78
7	Female	51	Negative	4
8	Male	49	Highly positive	242
9	Female	50	Positive	55
10	Female	50	Highly positive	258
11	Male	35	Highly positive	195
12	Female	68	Positive	61
13	Female	33	Highly positive	128
14	Male	53	Highly positive	211
15	Female	64	Highly positive	600
16	Male	60	Negative	3
17	Female	45	Positive	41
18	Male	70	Highly positive	210
19	Male	67	Highly positive	3700
20	Male	57	Highly positive	191
21	Female	55	Highly positive	171
22	Female	48	Moderate	57
23	Male	22	Highly positive	121
24	Female	65	Highly positive	227
25	Male	58	Negative	6
26	Female	75	Highly positive	210
27	Male	72	Highly positive	210
28	Male	63	Highly positive	210
29	Male	60	Highly positive	210
30	Female	70	Highly positive	150